Skip to main content
Log in

Recurrent Stenoses in Arteriovenous Fistula (AVF) for Dialysis Access: cuttIng ballooN angioplaSTy combined wITh paclitaxel drUg-coaTed balloon angioplasty, an observatIONal study (INSTITUTION Study)

  • Clinical Investigation
  • Venous Interventions
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

A Correction to this article was published on 15 February 2022

This article has been updated

Abstract

Purpose

To study the safety and efficacy of cutting balloon angioplasty (CBA) followed by paclitaxel drug-coated balloon (PCB) angioplasty for recurrent venous lesions in arteriovenous fistulas (AVFs).

Materials and Methods

We conducted a prospective single-arm cohort study of CBA followed by PCB angioplasty for recurrent AVF stenoses between September 2017 and April 2019. In total, 44 participants were recruited. Target lesions were included if they had recurred within 12 months post-angioplasty, were >  = 0.5 cm upstream from the arteriovenous anastomosis, and did not involve the central veins. Up to two non-target lesions per circuit/participant with the same definition were allowed. Lesions were considered separate when there was an intervening 2-cm segment of normal vessel. Technical success was defined as complete lesion effacement on angioplasty. End-points of target and circuit patency were evaluated clinically at 3, 6, and 12 months post-procedure.

Result

Technical success was 96% (42/44): Two participants were excluded from analysis due to the need for high-pressure balloon angioplasty as the target lesions did not efface with CBA. The median follow-up duration was 337.5 days. Mean stenosis pre- and post-angioplasty was 69.0% (51.6–84.8) and 20.8% (0–44.8), respectively. The target lesion primary, primary assisted and circuit patency for the entire study population (n = 42) were 61.6 ± 7.8%, 92.7 ± 4.0%, and 54.7 ± 7.9%, respectively, at 12 months. For participants without non-target lesions (n = 22), the rates were 77.3 ± 8.9%, 90.9 ± 6.1%, and 60.7 ± 11.0%, respectively, at 12 months.

Conclusion

CBA followed by PCB angioplasty appears safe and feasible for treatment of recurrent venous lesions in dysfunctional AVFs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Change history

References

  1. Daugirdas JT, Depner TA, Inrig J, Mehrotra R, Rocco MV, Suri RS, Weiner DE, Greer N, Ishani A, MacDonald R, Olson C, Rutks I, Slinin Y, Wilt TJ, Rocco M, Kramer H, Choi MJ, Samaniego-Picota M, Scheel PJ, Willis K, Joseph J, Brereton L. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884–930.

    Article  Google Scholar 

  2. Glanz S, Gordon DH, Butt KM, Hong J, Lipkowitz GS. The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas. Ann Surg. 1987;206(6):777–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Schwab SJ, Raymond JR, Saeed M, Newman GE, Dennis PA, Bollinger RR. Prevention of hemodialysis fistula thrombosis. Early Detect Venous Stenoses, Kidney Int. 1989;36(4):707–11.

    CAS  Google Scholar 

  4. P.P.G.M. Rooijens, J.H.M. Tordoir, T. Stijnen, J.P.J. Burgmans, A.A.E.A. Smet de, T.I. Yo, Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate. Eur J Vasc Endovasc Surg, 28(6) (2004) 583–589.

  5. Roy-Chaudhury P, Sukhatme VP, Cheung AK. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol. 2006;17(4):1112–27.

    Article  PubMed  Google Scholar 

  6. Chen B, Wang P, Brem A, Dworkin L, Liu Z, Gong R. Mineralocorticoid receptor: a hidden culprit for hemodialysis vascular access dysfunction. EBioMedicine. 2019;39:621–7.

    Article  PubMed  Google Scholar 

  7. Chang C-J, Ko P-J, Hsu L-A, Ko Y-S, Ko Y-L, Chen C-F, Huang C-C, Hsu T-S, Lee Y-S, Pang J-HS. Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis. 2004;43(1):74–84.

    Article  CAS  PubMed  Google Scholar 

  8. Peregrin JH, Roček M. Results of a peripheral cutting balloon prospective multicenter European registry in hemodialysis vascular access. Cardiovasc Intervent Radiol. 2007;30(2):212–5.

    Article  PubMed  Google Scholar 

  9. Aftab SA, Tay KH, Irani FG, Gong Lo RH, Gogna A, Haaland B, Tan SG, Chng SP, Pasupathy S, Choong HL, Tan BS. Randomized clinical trial of cutting balloon angioplasty versus high-pressure balloon angioplasty in hemodialysis arteriovenous fistula stenoses resistant to conventional balloon angioplasty. J Vasc Interv Radiol. 2014;25(2):190–8.

    Article  PubMed  Google Scholar 

  10. Irani FG, Teo TKB, Tay KH, Yin WH, Win HH, Gogna A, Patel A, Too CW, Chan S, Lo RHG, Toh LHW, Chng SP, Choong HL, Tan BS. Hemodialysis arteriovenous fistula and graft stenoses: randomized trial comparing drug-eluting balloon angioplasty with conventional angioplasty. Radiology. 2018;289(1):238–47.

    Article  PubMed  Google Scholar 

  11. Lookstein RA, Haruguchi H, Ouriel K, Weinberg I, Lei L, Cihlar S, Holden A. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. N Engl J Med. 2020;383(8):733–42.

    Article  CAS  PubMed  Google Scholar 

  12. Trerotola SO, Saad TF, Roy-Chaudhury P. The lutonix av randomized trial of paclitaxel-coated balloons in arteriovenous fistula stenosis: 2-year results and subgroup analysis. J Vasc Interv Radiol. 2020;31(1):1-14.e5.

    Article  PubMed  Google Scholar 

  13. Rajabi-Jaghargh E, Banerjee RK. Combined functional and anatomical diagnostic endpoints for assessing arteriovenous fistula dysfunction. World J Nephrol. 2015;4(1):6–18.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Quencer KB, Arici M. Arteriovenous fistulas and their characteristic sites of stenosis. Am J Roentgenol. 2015;205(4):726–34.

    Article  Google Scholar 

  15. Jennings WC, Galt SW, Shenoy S, Wang S, Ladenheim ED, Glickman MH, Kathuria P, Browne BJ. The Venous Window Needle Guide, a hemodialysis cannulation device for salvage of uncannulatable arteriovenous fistulas. J Vasc Surg. 2014;60(4):1024–32.

    Article  PubMed  Google Scholar 

  16. Gray RJ, Sacks D, Martin LG, Trerotola SO. Reporting standards for percutaneous interventions in dialysis access. J Vasc Interv Radiol. 2003;14(9):S433–42.

    Article  PubMed  Google Scholar 

  17. F.G. Irani, B.S. Tan, Drug coated balloons: are they the holy grail for dysfunctional dialysis arteriovenous fistulas?, CardioVascular and Interventional Radiology (2020).

  18. Cejna M. Cutting balloon: review on principles and background of use in peripheral arteries. Cardiovasc Intervent Radiol. 2005;28(4):400–8.

    Article  PubMed  Google Scholar 

  19. Saleh HM, Gabr AK, Tawfik MM, Abouellail H. Prospective, randomized study of cutting balloon angioplasty versus conventional balloon angioplasty for the treatment of hemodialysis access stenoses. J Vasc Surg. 2014;60(3):735–40.

    Article  PubMed  Google Scholar 

  20. Rasuli P, Chennur VS, Connolly MJ, Hadziomerovic A, Pomerleau FE, Ryan SE, French GJ, O’Kelly K, Aina R, Champagne P, Petrcich W. Randomized trial comparing the primary patency following cutting versus high-pressure balloon angioplasty for treatment of de novo venous stenoses in hemodialysis arteriovenous fistulae. J Vasc Interv Radiol. 2015;26(12):1840-6.e1.

    Article  PubMed  Google Scholar 

  21. Vesely TM, Siegel JB. Use of the peripheral cutting balloon to treat hemodialysis-related stenoses. J Vasc Interv Radiol. 2005;16(12):1593–603.

    Article  PubMed  Google Scholar 

  22. Ierardi AM, Franchin M, Fontana F, Piffaretti G, Duka E, Tonolini M, Miele V, Tozzi M, Carrafiello G. Usefulness of paclitaxel-releasing high-pressure balloon associated with cutting balloon angioplasty for treatment of outflow stenoses of failing hemodialysis arteriovenous shunts. Radiol Med. 2017;122(1):69–76.

    Article  PubMed  Google Scholar 

  23. Zheng J, Cui J, Meiyan Qing J, Irani Z. Safety and effectiveness of combined scoring balloon and paclitaxel-coated balloon angioplasty for stenosis in the hemodialysis access circuit. Diagn Inter Imaging. 2019;100(1):31–7.

    Article  CAS  Google Scholar 

Download references

Funding

Cutting balloons and drug-coated balloons are sponsored by a research grant from Boston Scientific Corporation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zehao Tan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Singhealth Centralized Institutional Review Board (CIRB reference number: 2017/2026) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised: The affiliations for two of the authors were mistakenly switched in the initial publication prior to revision on 15 February 2022. The affiliation for the author “Chieh Suai Tan” should be “Department of Renal Medicine” and “Tze Tec Chong” should be “Department of Vascular Surgery”.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tan, Z., Chan, S.X.J.M., Da Zhuang, K. et al. Recurrent Stenoses in Arteriovenous Fistula (AVF) for Dialysis Access: cuttIng ballooN angioplaSTy combined wITh paclitaxel drUg-coaTed balloon angioplasty, an observatIONal study (INSTITUTION Study). Cardiovasc Intervent Radiol 45, 646–653 (2022). https://doi.org/10.1007/s00270-021-03030-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-021-03030-w

Keywords

Navigation